OKI-219
OKI-219-101
Phase 1 small_molecule active
Quick answer
OKI-219 for Advanced Cancer is a Phase 1 program (small_molecule) at OnKure Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- OnKure Therapeutics
- Indication
- Advanced Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active